ATE192042T1 - Potenzierung von serotonin-wirkstoffresponz - Google Patents

Potenzierung von serotonin-wirkstoffresponz

Info

Publication number
ATE192042T1
ATE192042T1 AT96305999T AT96305999T ATE192042T1 AT E192042 T1 ATE192042 T1 AT E192042T1 AT 96305999 T AT96305999 T AT 96305999T AT 96305999 T AT96305999 T AT 96305999T AT E192042 T1 ATE192042 T1 AT E192042T1
Authority
AT
Austria
Prior art keywords
potentiation
serotonin
drug response
serotonin drug
tryptophan
Prior art date
Application number
AT96305999T
Other languages
English (en)
Inventor
David Taiwai Wong
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE192042T1 publication Critical patent/ATE192042T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT96305999T 1995-08-16 1996-08-16 Potenzierung von serotonin-wirkstoffresponz ATE192042T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US244095P 1995-08-16 1995-08-16

Publications (1)

Publication Number Publication Date
ATE192042T1 true ATE192042T1 (de) 2000-05-15

Family

ID=21700772

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96305999T ATE192042T1 (de) 1995-08-16 1996-08-16 Potenzierung von serotonin-wirkstoffresponz

Country Status (9)

Country Link
EP (1) EP0759299B1 (de)
AT (1) ATE192042T1 (de)
AU (1) AU6776196A (de)
DE (1) DE69607904T2 (de)
DK (1) DK0759299T3 (de)
ES (1) ES2145977T3 (de)
GR (1) GR3034007T3 (de)
PT (1) PT759299E (de)
WO (1) WO1997006792A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6231833B1 (en) 1999-08-05 2001-05-15 Pfizer Inc 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors
GB9714675D0 (en) * 1997-07-11 1997-09-17 Smithkline Beecham Plc Novel composition
AU764579B2 (en) * 1998-05-08 2003-08-21 Pharmacia & Upjohn Company New drug combinations of a N.A.R.I., preferably reboxetine, and pindolol
WO1999061014A2 (en) * 1998-05-28 1999-12-02 Sepracor Inc. Compositions and methods employing r(-) fluoxetine and other active ingredients
US6046242A (en) * 1998-11-27 2000-04-04 Basf Aktiengesellschaft Use of aryl-substituted cyclobutylalkylamines for treating urinary incontinence
AR021155A1 (es) 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
US6218395B1 (en) * 1999-08-02 2001-04-17 Conrad Melton Swartz Centrally-acting beta-blockers and serotonin-enhancers for the treatment of anxiety disorders and adjustment disorders with anxiety
GB0004003D0 (en) * 2000-02-22 2000-04-12 Knoll Ag Therapeutic agents
US7034059B2 (en) 2001-07-02 2006-04-25 Sepracor Inc. Methods of using norfluoxetine
US6635675B2 (en) * 2001-11-05 2003-10-21 Cypress Bioscience, Inc. Method of treating chronic fatigue syndrome
US6602911B2 (en) 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
US7704527B2 (en) 2002-10-25 2010-04-27 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
WO2004039361A1 (en) 2002-10-25 2004-05-13 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040132826A1 (en) * 2002-10-25 2004-07-08 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
EP1592453A1 (de) * 2003-01-28 2005-11-09 Collegium Pharmaceutical, Inc. Multiparticulate aufbau von milnacipran für orale einnahme
US7994220B2 (en) 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
CA2759180A1 (en) * 2009-05-13 2010-11-18 Sunovion Pharmaceuticals Inc. Compositions comprising transnorsertraline and serotonin receptor 1a agonists/antagonists and uses thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155669A (en) * 1962-06-22 1964-11-03 Res Lab Dr C Janssen N V 2, 4, 8-triaza-spiro (4, 5) dec-2-enes
NL300886A (de) * 1962-11-23
US3471515A (en) * 1965-02-01 1969-10-07 Sandoz Ag (2-hydroxy-3-substituted aminopropoxy)indoles
US3466325A (en) * 1965-04-30 1969-09-09 Haessle Ab 1-(ortho-alkenyl phenoxy) - 2-hydroxy-3-isopropylaminopropanes and the salts thereof
DE1668055B2 (de) * 1967-03-10 1973-09-06 Farbwerke Hoechst AG, vormals Mei ster Lucius & Bruning, 6000 Frankfurt Basisch substituierte cyclopentylphenolaether, deren salze mit physiologisch vertraeglichen saeuren und verfahren zu deren herstellung
GB1308191A (en) * 1970-04-06 1973-02-21 Science Union & Cie Thiochroman derivatives and a process for preparing them
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
NL7503310A (nl) * 1975-03-20 1976-09-22 Philips Nv Verbindingen met antidepressieve werking.
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
FR2508035A1 (fr) * 1981-06-23 1982-12-24 Fabre Sa Pierre Derives d'aryl-1-aminomethyl-2 cyclopropanes carboxamides (z), leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central
US4853377A (en) * 1985-10-15 1989-08-01 Pollack Robert L Method and composition for increasing production of serotonin
US4956388A (en) * 1986-12-22 1990-09-11 Eli Lilly And Company 3-aryloxy-3-substituted propanamines
US5013761A (en) * 1988-06-03 1991-05-07 Eli Lilly And Company Serotonin antagonists
GB8909209D0 (en) * 1989-04-22 1989-06-07 Wyeth John & Brother Ltd Piperazine derivatives
AU645681B2 (en) * 1991-05-02 1994-01-20 John Wyeth & Brother Limited Piperazine derivatives
CA2134038C (en) * 1994-06-16 1997-06-03 David Taiwai Wong Potentiation of drug response
EP0714663A3 (de) * 1994-11-28 1997-01-15 Lilly Co Eli Potenzierung von Wirkstoffresponz durch Serotonin 1A Rezeptor Antagonisten

Also Published As

Publication number Publication date
DK0759299T3 (da) 2000-08-07
EP0759299B1 (de) 2000-04-26
ES2145977T3 (es) 2000-07-16
EP0759299A1 (de) 1997-02-26
PT759299E (pt) 2000-09-29
GR3034007T3 (en) 2000-11-30
DE69607904T2 (de) 2000-10-05
WO1997006792A1 (en) 1997-02-27
AU6776196A (en) 1997-03-12
DE69607904D1 (de) 2000-05-31

Similar Documents

Publication Publication Date Title
ATE192042T1 (de) Potenzierung von serotonin-wirkstoffresponz
NO2013002I1 (no) Aklidinium haogenid (Aklidinium bromid)
DK0531410T3 (da) (+)-alfa-(2,3-Demethoxyphenyl)-1-(2-(4-fluorphenyl)ethyl)-4-piperidinmethanol
EA199900561A1 (ru) Производные сульфонамида, способ их получения и их использование в качестве лекарственных средств
DE69636104D1 (de) Orale pharmazeutische Zusammensetzung mit verzögerter Wirkstofffreigabe von Protonenpumpen-Hemmern
EA200101156A1 (ru) ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НОВОГО ТИПА НА ОСНОВЕ ОБЛАДАЮЩИХ ХОЛИНЕРГИЧЕСКИМ ДЕЙСТВИЕМ СОЕДИНЕНИЙ И β-МИМЕТИКОВ
EA200500776A1 (ru) ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ АГОНИСТ β3-АДРЕНОРЕЦЕПТОРА И ИНГИБИТОР ОБРАТНОГО ЗАХВАТА СЕРОТОНИНА И/ИЛИ НОРЭПИНЕФРИНА, И ЕЕ ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ НАРУШЕНИЙ ФУНКЦИИ МОЧЕВОГО ПУЗЫРЯ
CY2004005I1 (el) Σουλφοναμιδη, η παρασκευη και χρηση της ως φαρμακου και ενδιαμεσης ουσιας
EA200100022A1 (ru) Композиции с контролируемым высвобождением пароксетина
EA200200571A1 (ru) Новая композиция и ее применение
EA199700425A1 (ru) Производные пиперазина
EP0714663A3 (de) Potenzierung von Wirkstoffresponz durch Serotonin 1A Rezeptor Antagonisten
FI963786A7 (fi) Uusia 1,4-disubstituoituja piperidiinijohdannaisia, jotka ovat käyttök elpoisia glutamaattireseptoriin vaikuttavina lääkeaineina
ES2071663T3 (es) Analogo de fluoxetina.
ES2191942T3 (es) Nueva utilizacion de un antagonista especifico de los receptores 5ht2a.
KR920002151A (ko) 15-케토-프로스타글란딘 화합물에 의한 염증성 질환 치료
DK0590150T3 (da) (-)-(S)-2,8-dimethyl-3-methylen-1-oxa-8-azaspiro[4,5]decan-L-tartrat
NO942343L (no) Farmasöytisk preparat med analgetisk aktivitet
DE69808440D1 (de) Verwendung von (+)mefloquine zur behandlung von malaria
CO4230161A1 (es) Compuestos neuroprotectores que bloquean los receptores de aminoacidos excitativos y antiisquemicos
EE9400296A (et) Piperidinüültioindooli derivaadid, ravimvormid, aktiivne valuvaigisti, nende valmistamise meetodid
SE9302218D0 (sv) New use
FI951277L (fi) Uudet N,N,N',N'-tetrasubstituoituneet 1,2-etaanidiamiinijohdannaisyhdisteet
AR023452A1 (es) Utilizacion del osanetant para preparacion de medicamentos utiles en el tratamiento de los trastornos del humor
CY1108050T1 (el) Η χρηση της μεκαμυλαμινης για τη θεραπεια των ανταποκρινομενων στη νικοτινη νευροψυχιατρικων διαταραχων

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee